Search

Your search keyword '"BCG vaccines -- Health aspects"' showing total 200 results
Start Over Descriptor "BCG vaccines -- Health aspects"
200 results on '"BCG vaccines -- Health aspects"'

1. Immune to ageing

Subjects
BCG vaccines -- Health aspects, BCG -- Health aspects, Hypertension -- Health aspects
Abstract

IN JUST over five years I will turn 60, which is a daunting prospect. I already have one age-related disease – hypertension – and, given the odds, will be lucky [...]

Published
2024

2. Immune to ageing

Subjects
Vaccination -- Health aspects, BCG vaccines -- Health aspects, BCG -- Health aspects, Hypertension -- Health aspects
Abstract

Features Cover story Immune to ageing It may soon be possible to vaccinate ourselves against diseases of old age. Graham Lawton investigates IN JUST over five years I will turn [...]

Published
2024

3. MMR vaccination induces trained immunity via functional and metabolic reprogramming of [gamma][delta] T cells

Author

Roring, Rutger J., Debisarun, Priya A., Botey-Bataller, Javier, Suen, Tsz Kin, Bulut, Ozlem, Kilic, Gizem, Koeken, Valerie A.C.M., Sarlea, Andrei, Bahrar, Harsh, Dijkstra, Helga, Lemmers, Heidi, Gossling, Katharina L., Ruchel, Nadine, Ostermann, Philipp N., Muller, Lisa, Schaal, Heiner, Adams, Ortwin, Borkhardt, Arndt, Ariyurek, Yavuz, de Meijer, Emile J., Kloet, Susan L., Oever, Jaap ten, Placek, Katarzyna, Li, Yang, and Netea, Mihai G.

Subjects
Vaccination -- Health aspects, Tetanus antitoxin -- Health aspects, T cells -- Health aspects, BCG vaccines -- Health aspects, RNA sequencing -- Health aspects, BCG -- Health aspects, Measles-mumps-rubella vaccine -- Health aspects, Ethylenediaminetetraacetic acid -- Health aspects, Killer cells -- Health aspects, Health care industry
Abstract

The measles, mumps, and rubella (MMR) vaccine protects against all-cause mortality in children, but the immunological mechanisms mediating these effects are poorly known. We systematically investigated whether MMR can induce long- term functional changes in innate immune cells, a process termed trained immunity, that could at least partially mediate this heterologous protection. In a randomized, placebo-controlled trial, 39 healthy adults received either the MMR vaccine or a placebo. Using single-cell RNA-Seq, we found that MMR caused transcriptomic changes in [CD14.sup.+] monocytes and NK cells, but most profoundly in [gamma][delta] T cells. Monocyte function was not altered by MMR vaccination. In contrast, the function of [gamma][delta] T cells was markedly enhanced by MMR vaccination, with higher production of TNF and IFN-[gamma], as well as upregulation of cellular metabolic pathways. In conclusion, we describe a trained immunity program characterized by modulation of [gamma][delta] T cell function induced by MMR vaccination., Introduction Vaccines are developed to target specific pathogens. However, an accumulating body of evidence suggests that certain live-attenuated vaccines provide a broad spectrum of protection against heterologous infections as well [...]

Published
2024
Full Text
View/download PDF

6. ROUTINE VACCINATION COVERAGE - WORLDWIDE, 2023

Subjects
World Bank Group. World Bank, World Health Organization, Vaccination -- Health aspects, BCG vaccines -- Health aspects, BCG -- Health aspects, Public health -- Health aspects, United States. Centers for Disease Control and Prevention
Abstract

ATLANTA, GA -- The following information was released by the Centers for Disease Control and Prevention (CDC): Abstract In 2020, the World Health Assembly endorsed the Immunization Agenda 2030 (IA2030), [...]

Published
2024

7. Adstiladrin Now Available for High-Risk, Non-Muscle-Invasive Bladder Cancer

Author

Park, Brian

Subjects
Interferon -- Health aspects, BCG vaccines -- Health aspects, BCG -- Health aspects, Bladder cancer -- Drug therapy, Genetic vectors -- Health aspects, Health, Adstiladrin (Medication) -- Health aspects
Abstract

Adstiladrin[sup.®] (nadofaragene firadenovec-vncg) is now available for the treatment of adults with high-risk, Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle-invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) with or without papillary tumors. [...]

Published
2024

8. Pilomatricoma growing at the SARS-CoV-2 mRNA vaccination site

Author

Erkayman, Merve, Güven, Melike, Bingöl, Merve, Bulut, Numan, and Demirtas, Rabia

Subjects
Vaccination -- Health aspects, BCG vaccines -- Health aspects, BCG -- Health aspects, Messenger RNA -- Health aspects, Health, Comirnaty (Vaccine) -- Health aspects
Abstract

Byline: Merve. Erkayman, Melike. Güven, Merve. Bingöl, Numan. Bulut, Rabia. Demirtas A healthy 21-year-old woman was presented to our outpatient clinic with an asymptomatic swelling on her left arm. She [...]

Published
2023

9. Reduced Bacille Calmette-Guerin-specific IgG titres among babies born to mothers with Active Tuberculosis Disease in Uganda

Subjects
Medical research -- Health aspects, Medicine, Experimental -- Health aspects, BCG vaccines -- Health aspects, BCG -- Health aspects, Diseases -- Health aspects, Infants -- Health aspects, Tuberculosis -- Health aspects, Vaccines -- Health aspects, Immunoglobulin G -- Health aspects, Health
Abstract

2024 OCT 30 (NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Weekly -- According to news reporting based on a preprint abstract, our journalists obtained the following quote [...]

Published
2024

10. Non-Muscle Invasive Bladder Cancer Market Set to Reach New Heights Amidst Growing Pipeline and Research Initiatives | DelveInsight

Subjects
Adstiladrin (Medication) -- Health aspects, Anktiva (Medication) -- Health aspects, Keytruda (Medication) -- Health aspects, Oncology, Experimental -- Health aspects, BCG vaccines -- Health aspects, BCG -- Health aspects, Bladder cancer -- Health aspects, Cancer -- Care and treatment -- Research, Pharmaceutical industry -- Health aspects, Ferring Pharmaceuticals, United States. Food and Drug Administration
Abstract

2024 OCT 7 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Gene Therapy Week -- Non-muscle-invasive bladder cancer (NMIBC) is a type of bladder cancer where the tumor [...]

Published
2024

11. Mtb specific HLA-E restricted T cells are induced during Mtb infection but not after BCG administration in non-human primates and humans

Subjects
Vaccination -- Health aspects, T cells -- Health aspects, BCG vaccines -- Health aspects, HLA histocompatibility antigens -- Health aspects, BCG -- Health aspects, Vaccines -- Health aspects, Histocompatibility antigens -- Health aspects, Health
Abstract

2024 SEP 11 (NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Weekly -- According to news reporting based on a preprint abstract, our journalists obtained the following quote [...]

Published
2024

12. ImmunityBio Announces Study of ANKTIVA[R] in Combination with the AdHER2DC Cancer Vaccine as a Potential Therapy to Control Endometrial Cancer

Subjects
United States. Securities and Exchange Commission, United States. National Cancer Institute, Oncology, Experimental -- Health aspects, BCG vaccines -- Health aspects, BCG -- Health aspects, Endometrial cancer -- Health aspects, Cancer -- Care and treatment -- Research, Cancer vaccines -- Health aspects, Business, Business, international, Anktiva (Medication) -- Health aspects
Abstract

* The QUILT 502 trial is testing ImmunityBio's N-803 (ANKTIVA[R]) in combination with the AdHER2DC investigational vaccine for endometrial cancer, a gynecological cancer with lower survival rates and limited effective [...]

Published
2024

13. Nigeria: Special Report - in Northwest Nigeria, Insecurity Is Fueling Medical Deserts

Subjects
BCG vaccines -- Health aspects, BCG -- Health aspects, Local government -- Nigeria, Primary health care -- Health aspects, Children -- Health aspects, Pregnant women -- Health aspects, News, opinion and commentary
Abstract

Byline: Qosim Suleiman Terrorism in the Nigerian north-west is worsening access to primary healthcare, maternal and child health, malnutrition, and increasing mortality rates. A blood bag is hung on a [...]

Published
2024

14. TREMFYA (guselkumab) studies underscore its potential to be the only IL-23 inhibitor to offer both subcutaneous and intravenous induction

Subjects
Johnson & Johnson, Medical research -- Health aspects, Medicine, Experimental -- Health aspects, BCG vaccines -- Health aspects, BCG -- Health aspects, Pharmaceutical industry -- Health aspects, Business, News, opinion and commentary, Tremfya (Medication) -- Health aspects, Stelara (Medication) -- Health aspects
Abstract

TREMFYA Phase 3 Crohn's disease study achieves all primary and secondary endpoints SPRING HOUSE, Pa., June 20, 2024 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced positive topline results [...]

Published
2024

17. Bladder cancer patient, 27, reveals first symptoms after mistaking them for infection; Abbie Jarvis, 27, from Cheshire, was 'left numb' when she was diagnosed with grade three bladder cancer -she is sharing her symptoms with others, who are also below the average age for diagnosis

Subjects
BCG vaccines -- Health aspects, Cancer patients -- Care and treatment, BCG -- Health aspects, Bladder cancer -- Care and treatment, Infection -- Care and treatment, General interest, News, opinion and commentary
Abstract

Byline: By, Neil Shaw & Monica Charsley A blood cancer patient says doctors initially thought she had a water infection before she was diagnosed with the tumour. Abbie Jarvis, of [...]

Published
2024

19. Therapeutic approaches in non-muscle invasive bladder cancer

Subjects
BCG vaccines -- Health aspects, BCG -- Health aspects -- Excerpts, Bladder cancer -- Health aspects -- Excerpts, Business, Health care industry
Abstract

Urology Times' Viewpoints program brings together expert panels for in-depth discussions on key clinical topics. In this installment, 5 clinicians engage in a detailed exploration of non-muscle invasive bladder cancer. [...]

Published
2024

20. Tuberculosis Testing and Latent Tuberculosis Infection Treatment Practices Among Health Care Providers--United States, 2020-2022

Author

Caruso, Elise, Mangan, Joan M., Maiuri, Allison, Bouwkamp, Beth, and DeLuca, Nickolas

Subjects
United States. Centers for Disease Control and Prevention, Blood -- Medical examination, BCG vaccines -- Health aspects, BCG -- Health aspects, Prescription writing -- Health aspects, Health care industry -- Health aspects, Tuberculosis -- Health aspects, Rifamycins -- Health aspects, Rifapentine -- Health aspects, Health care industry, Health
Abstract

Introduction CDC estimates that up to 13 million persons in the United States have latent tuberculosis infection (LTBI) (1). Approximately 5%-10% of persons with LTBI in the United States who [...]

Published
2023

22. Nadofaragene firadenovec shows durable efficacy in NMIBC: Median duration of CR was approximately 10 months across cohorts

Author

Clarke, Hannah

Subjects
BCG vaccines -- Health aspects, BCG -- Health aspects, Bladder cancer -- Diagnosis -- Care and treatment, Business, Health care industry
Abstract

Nadofaragene firadenovec-vncg (Adstiladrin) demonstrated durable efficacy and long-term safety at 3-year follow-up among 2 cohorts of patients with high-risk, BCG-unresponsive non-muscle-invasive bladder cancer (NMIBC), according to data from a phase [...]

Published
2024

24. Ractigen's RAG-01 becomes second saRNA drug globally to advance to clinical stage, says GlobalData

Subjects
BCG vaccines -- Health aspects, BCG -- Health aspects, RNA -- Health aspects, Drug approval -- Health aspects, Business, Chemicals, plastics and rubber industries
Abstract

Ractigen Therapeutics, headquartered in China, submitted a clinical trial application for RAG-01 in Australia. This application paves the way for Phase I trial of RAG-01 in patients with non-muscle-invasive bladder cancer (NMIBC) who have not responded to Bacillus Calmette-Guerin (BCG) therapy, making it globally the second small activating RNA (saRNA) drug to advance into the clinical stage, says GlobalData, a leading data and analytics company. This development signifies a remarkable advancement in RNA-based therapeutic applications, especially in the context of challenging cancer treatments. RAG-01 has shown promising results in preclinical tumour suppression and a solid safety profile. The classes of RNA-based therapies are small-interfering RNAs (siRNA), antisense oligonucleotides (ASOs), saRNA, circular RNA (circRNA), mRNA therapies, and aptamers. According to GlobalData's Pharmaceutical Intelligence Center, the highest development phase of RNA-based therapies for the treatment of oncology is still Phase III for mRNA vaccines (mRNA-4157) and Phase II for both siRNA (lixadesiran with pixofisiran) and saRNA (MTL-CEBPA) drugs. As there are no approved RNA-based therapies for oncology yet, mRNA, siRNA, and saRNA drugs become more noteworthy within this therapy area from a research and development (R&D) perspective. Mina Therapeutics Ltd's MTL-CEBPA is the first saRNA to advance into clinical trials globally. Currently, it is being tested in Phase II clinical trials in combination with sorafenib for hepatocellular carcinoma (HCC) as second-line therapy in the US and Phase I clinical trials in combination with pembrolizumab for solid tumours. MTL-CEBPA demonstrated an acceptable safety profile and potential synergistic efficacy with sorafenib in HCC. Further, in combination with pembrolizumab, it is safe and well tolerated in heavily pre-treated patients across multiple tumour types. Original source: Global Data, website: http://www.energy.globaldata.com, Copyright Global Data 2023., regulations and rulings; research and development; anticancer drugs; antisense oligonucleotides; biological therapeutics; biotechnology vaccines; cancer vaccines; circular ribonucleic acid; lixadesiran; messenger RNA; monoclonal antibodies; pembrolizumab; pixofisiran; ribonucleic acids; small activating [...]

Published
2023

25. Everything you need to know about tuberculosis as map shows rise in cases of Victorian disease; TB cases have increased in recent months across England -here's what you should know about the symptoms of the infection, how it is spread, and who can get a vaccine

Subjects
BCG vaccines -- Health aspects, BCG -- Health aspects, Tuberculosis -- Health aspects, Disease transmission -- Health aspects, Vaccines -- Health aspects, Antibiotics -- Health aspects, General interest, News, opinion and commentary
Abstract

Byline: By, Bradley Jolly & Catherine Addison-Swan Health experts have urged people to familiarise themselves with the symptoms of a Victorian disease ahead of winter as recent data shows a [...]

Published
2023

28. Messenger RNA Vaccines: Beckoning of a New Era in Cancer Immunotherapy

Author

Copur, Mehmet Sitki

Subjects
BCG vaccines -- Health aspects, BCG -- Health aspects, Messenger RNA -- Health aspects, Immunotherapy -- Health aspects, Antigens -- Health aspects, Dendritic cells -- Health aspects, Cancer -- Drug therapy -- Prevention, Cancer vaccines -- Health aspects, Genetic transcription -- Health aspects, Health
Abstract

Messenger RNA (mRNA) vaccines are a relatively new class of vaccines. They combine the potential of mRNA to encode for almost any protein with an excellent safety profile and a flexible production process. During the last decade, the mRNA vaccine approach has been increasingly recognized and viewed as a versatile tool for the development of new innovative therapeutics not only in infectious disease settings but also in cancer. mRNA vaccines traditionally consist of a messenger RNA synthesized by in vitro transcription using a bacteriophage RNA polymerase and a template DNA that encodes the antigen(s) of interest. Once administered and internalized by host cells, the mRNA transcripts are translated directly in the cytoplasm of the cell. The resulting antigens are presented to the immune system cells to stimulate an immune response. Dendritic cells (DCs) can be utilized as a carrier by delivering tumor-associated antigen mRNAs or total tumor RNA to their cytoplasm; then, the mRNA-loaded DCs can be delivered to the host to elicit a specific immune response. Recently, 2 mRNA vaccines were approved for the first time for human use--to prevent COVID-19 infection--bringing excitement for the future possibilities of this approach for cancer immunotherapy as well as for preventing other infectious diseases., Introduction Messenger RNA (mRNA) vaccines have generated significant excitement not only for their potential to complement or even replace traditional vaccines against infectious diseases, but also for their potential use [...]

Published
2021

29. Data on Obesity, Fitness and Wellness Detailed by Researchers at Yale University (Surveillance and Office Management of Low-grade Ta Bladder Tumors)

Subjects
Medical research -- Health aspects, Medicine, Experimental -- Health aspects, Tumors -- Health aspects, BCG vaccines -- Health aspects, BCG -- Health aspects, Physical fitness -- Health aspects, Company business management, Health, Yale University -- Management
Abstract

2023 FEB 18 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Data detailed on Obesity, Fitness and Wellness have been presented. According to [...]

Published
2023

31. Member of UMass Boston community diagnosed with active tuberculosis -- The Mass Media

Author

Collins, Nick

Subjects
BCG vaccines -- Health aspects, BCG -- Health aspects, Tuberculosis -- Health aspects, Student health services -- Health aspects, News, opinion and commentary, Sports and fitness
Abstract

Byline: Nick Collins UMass Boston's University Health Services released a mass email Monday, Nov. 6 that notified students, staff and faculty of a campus member who was recently diagnosed with [...]

Published
2023

32. First Bladder Cancer Patient Dosed with Commercially Available Intravesical Gene Therapy ADSTILADRIN[R] (nadofaragene firadenovec-vncg)

Subjects
United States. Food and Drug Administration, Ferring Pharmaceuticals, Medical research -- Health aspects, Medicine, Experimental -- Health aspects, BCG vaccines -- Health aspects, Genes -- Health aspects, BCG -- Health aspects, Gene therapy -- Health aspects, Bladder cancer -- Care and treatment, Cancer -- Genetic aspects, Drug approval -- Health aspects, Pharmaceutical industry -- Health aspects, Business, Business, international, Adstiladrin (Medication) -- Health aspects
Abstract

* Urologists treating eligible high-risk bladder cancer patients at participating early experience program clinics in the U.S. can now prescribe the first and only FDA-approved intravesical gene therapy * Ferring [...]

Published
2023

33. Ability of mycobacterial pathogens to establish a persistent infection is lost by deletion of a single gene, rel, regulator of the stringent response

Subjects
Medical research -- Health aspects, Medicine, Experimental -- Health aspects, T cells -- Health aspects, Genetic research -- Health aspects, BCG vaccines -- Health aspects, BCG -- Health aspects, Infection -- Health aspects, Health
Abstract

2024 FEB 2 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- According to news reporting based on a preprint abstract, our journalists obtained the [...]

Published
2024

34. Investigators from Department of Hypertension and Nephrology Target Interstitial Lung Disease (Disseminated Bacillus Calmette-guerin Infection With Rhabdomyolysis, Acute Kidney Injury, and Interstitial Pneumonia After Bacillus Calmette-guerin ...)

Subjects
Medical research -- Health aspects, Medicine, Experimental -- Health aspects, Bacterial pneumonia -- Care and treatment, BCG vaccines -- Health aspects, BCG -- Health aspects, Rhabdomyolysis -- Care and treatment, Pneumonia -- Care and treatment, Hypertension -- Care and treatment, Health
Abstract

2024 JAN 29 (NewsRx) -- By a News Reporter-Staff News Editor at Respiratory Therapeutics Week -- Investigators discuss new findings in Lung Diseases and Conditions - Interstitial Lung Disease. According [...]

Published
2024

35. Vaccine boosts innate immunity in people with dormant immune cells

Subjects
BCG vaccines -- Health aspects, BCG -- Health aspects, Immunotherapy -- Health aspects, Vaccines -- Health aspects, Health
Abstract

2024 JAN 24 (NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Weekly -- Humans are protected by two branches of the immune system. Innate immunity provides built-in defense [...]

Published
2024

36. BCG activation of trained immunity is associated with induction of cross reactive COVID-19 antibodies in a BCG vaccinated population

Subjects
Vaccination -- Health aspects, BCG vaccines -- Health aspects, BCG -- Health aspects, Antitubercular agents -- Health aspects, Viral antibodies -- Health aspects, Tuberculosis -- Health aspects, Antibodies -- Health aspects, Virus diseases -- Health aspects, Business, Health, Health care industry
Abstract

2024 JAN 21 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Letter on the CDC & FDA -- According to news reporting based on a preprint abstract, our [...]

Published
2024

37. Reports Summarize Mycobacteria Study Results from Karolinska Institute (Bcg Infection Dose Guides Dendritic Cell Migration and T Cell Priming In the Draining Lymph Node)

Subjects
T cells -- Health aspects, BCG vaccines -- Health aspects, BCG -- Health aspects, Infection -- Health aspects, Dendritic cells -- Health aspects, Vaccines -- Health aspects, Health
Abstract

2023 DEC 20 (NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Weekly -- Data detailed on Gram-Positive Bacteria - Mycobacteria have been presented. According to news originating from [...]

Published
2023

38. Les vaccins, la fin des maladies tueuses en série

Subjects
Vaccination -- Health aspects, BCG vaccines -- Health aspects, BCG -- Health aspects
Abstract

par Victor Cascales Depuis l’avènement du virus du Covid-19, au début de l’année 2020, la vaccination a été de nouveau propulsée en première ligne de l’actualité sanitaire mondiale. Alors que [...]

Published
2022

39. WHO's urgent call: World needs new antimicrobial resistance vaccines

Subjects
BCG vaccines -- Health aspects, BCG -- Health aspects, Drug resistance in microorganisms -- Health aspects, Bacterial infections -- Health aspects, Infection -- Health aspects, Public health -- Health aspects, Vaccines -- Health aspects, Environmental issues, Regional focus/area studies, World Health Organization
Abstract

India, July 12 -- Urges equitable and global access to existing vaccines as well The World Health Organization has stressed the need to accelerate trials for antimicrobial resistance-related vaccines in [...]

Published
2022

40. Screening of Latent Tuberculous Infection (LTBI) before starting anti-tumor necrosis factor therapy in patients with psoriasis: A primer for clinical dermatologist

Author

Pradhan, Swetalina, Madke, Bhushan, Neema, Shekhar, Kabra, Poonam, Singh, Adarsh, and Yadav, Sangita

Subjects
United States. Centers for Disease Control and Prevention, Psoriasis -- Health aspects, Tumors -- Health aspects, BCG vaccines -- Health aspects, BCG -- Health aspects, Tuberculosis -- Health aspects, Tumor necrosis factor -- Health aspects, Monoclonal antibodies -- Health aspects, Medical screening -- Health aspects, Necrosis -- Health aspects, Health, World Health Organization
Abstract

Byline: Swetalina. Pradhan, Bhushan. Madke, Shekhar. Neema, Poonam. Kabra, Adarsh. Singh, Sangita. Yadav Anti-tumor necrosis agents are being increasingly used in the management of moderate to severe psoriasis. Therapy with [...]

Published
2021

41. Systemic Bacillus Calmette-Guerin infection secondary to inadvertent intravenous injection

Author

Farooq, Mudasir, Nagasubramanian, Santhosh, and Samuel, Benedict

Subjects
BCG vaccines -- Health aspects, BCG -- Health aspects, Infection -- Health aspects, Health
Abstract

Byline: Mudasir. Farooq, Santhosh. Nagasubramanian, Benedict. Samuel Disseminated BCG infection (BCG-osis) secondary to intravesical BCG given for high-risk non-muscle invasive bladder cancer has been reported. We report the successful management [...]

Published
2021

42. Drug & Device Pipeline News

Subjects
Oncology, Experimental -- Health aspects, BCG vaccines -- Health aspects, BCG -- Health aspects, Rifabutin -- Health aspects, Vaccines -- Health aspects, Cancer -- Research, Health
Abstract

This week's Pipeline features approval of an IDE for a study of an atrioventricular interval modulation therapy, two cancer drug approvals from the European Commission and initiation of a phase [...]

Published
2023

43. TB vaccine discovery paves path to end no. 1 killer of people living with HIV

Subjects
HIV (Viruses) -- Prevention, BCG vaccines -- Health aspects, BCG -- Health aspects, Antitubercular agents -- Health aspects, Tuberculosis vaccines -- Health aspects, Tuberculosis -- Prevention, Medical colleges -- Health aspects, HIV patients -- Health aspects, Primates -- Health aspects, AIDS vaccines -- Health aspects, Pharmaceuticals and cosmetics industries, Health, Science and technology
Abstract

2023 OCT 23 (NewsRx) -- By a News Reporter-Staff News Editor at AIDS Vaccine Week -- Scientists at the University of Pittsburgh School of Medicine have discovered a tuberculosis (TB) [...]

Published
2023

44. Capturing recent Mycobacterium tuberculosis infection by tuberculin skin test vs. interferon-gamma release assay

Subjects
Interferon -- Health aspects, Medical tests -- Health aspects, BCG vaccines -- Health aspects, BCG -- Health aspects, Tuberculin -- Health aspects, Biological response modifiers -- Health aspects, Tuberculosis -- Health aspects, Skin -- Health aspects, Health
Abstract

2023 OCT 3 (NewsRx) -- By a News Reporter-Staff News Editor at TB & Outbreaks Week -- According to news reporting based on a preprint abstract, our journalists obtained the [...]

Published
2023

45. Data from U.S. Food and Drug Administration (FDA) Advance Knowledge in Vaccination (Transcriptional Signatures Measured In Whole Blood Correlate With Protection Against Tuberculosis In Inbred and Outbred Mice)

Subjects
United States. Food and Drug Administration, Vaccination -- Health aspects, Medical research -- Health aspects, Medicine, Experimental -- Health aspects, BCG vaccines -- Health aspects, BCG -- Health aspects, Tuberculosis -- Health aspects, Genetic transcription -- Health aspects, Health, Public Library of Science
Abstract

2023 SEP 25 (NewsRx) -- By a News Reporter-Staff News Editor at Tuberculosis Week -- Research findings on Public Health - Vaccination are discussed in a new report. According to [...]

Published
2023

46. Reports from Beth Israel Deaconess Medical Center Advance Knowledge in Bacillus Calmette-Guerin Vaccines [Bacillus Calmette-guerin (Bcg) Vaccination To Treat Endometriosis]

Subjects
Vaccination -- Health aspects, Medical centers -- Health aspects, BCG vaccines -- Health aspects, BCG -- Health aspects, Cancer -- Prevention, Endometriosis -- Health aspects, Health, Women's issues/gender studies, Beth Israel Deaconess Medical Center
Abstract

2022 JAN 6 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Investigators publish new report on Immunization and Public Health - Bacillus Calmette-Guerin Vaccines. According [...]

Published
2022

47. New Program From Gardenuity and Travel Nurse Across America (TNAA) Delivers the Wellness Power of Gardening to Travel Nurses and Allied Professionals Nationwide

Subjects
Gardening -- Health aspects, BCG vaccines -- Health aspects, BCG -- Health aspects, Employment services -- Health aspects, Health care industry -- Health aspects, Nurses -- Health aspects, Health care industry, Business, Business, international
Abstract

Launch of a new year-round effort to meet the unique needs of travel nurses and allied professionals timed with National Nurses Week, May 6-12 DALLAS -- In recognition of National [...]

Published
2023

48. FDA Approves Merck's KEYTRUDA[R] (pembrolizumab) in Combination With Padcev[R] (enfortumab vedotin-ejfv) for First-Line Treatment of Certain Patients With Locally Advanced or Metastatic Urothelial Cancer

Subjects
United States. Food and Drug Administration, Merck & Company Inc., BCG vaccines -- Health aspects, Metastasis -- Drug therapy, BCG -- Health aspects, Biological products -- Health aspects, Chemotherapy -- Health aspects, Drug approval -- Health aspects, Cancer -- Drug therapy -- Chemotherapy, Pharmaceutical industry -- Health aspects, Business, Business, international, Padcev (Medication) -- Health aspects, Keytruda (Medication) -- Health aspects
Abstract

First approved therapeutic regimen that combines an anti-PD-1 and an antibody-drug conjugate in the US in these patients RAHWAY, N.J. -- Merck (NYSE: MRK), known as MSD outside of the [...]

Published
2023

49. Reports from Royal Melbourne Institute of Technology - RMIT University Highlight Recent Findings in Mycobacterium tuberculosis (Prospective Subunit Nanovaccine Against Mycobacterium Tuberculosis Infection-cubosome Lipid Nanocarriers of Cord ...)

Subjects
Medical research -- Health aspects, Medicine, Experimental -- Health aspects, BCG vaccines -- Health aspects, BCG -- Health aspects, Tuberculosis vaccines -- Health aspects, Tuberculosis -- Health aspects, Health
Abstract

2023 JUL 26 (NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Weekly -- Research findings on Gram-Positive Bacteria - Mycobacterium tuberculosis are discussed in a new report. According [...]

Published
2023

50. Sierra Leone’s President Julius Maada Bio Chairs Session to Build Momentum for Routine Immunisation Recovery in Africa on the Side Event of African Union (AU) Assembly

Subjects
BCG vaccines -- Health aspects, Immunization -- Health aspects, BCG -- Health aspects, Vaccines -- Health aspects, Business, Business, international, African Union
Abstract

M2 PRESSWIRE-February 20, 2023-: Sierra Leone’s President Julius Maada Bio Chairs Session to Build Momentum for Routine Immunisation Recovery in Africa on the Side Event of African Union (AU) Assembly [...]

Published
2023

Catalog

Books, media, physical & digital resources
See catalog results